hoʻohui2
He aha nā meaʻai i ʻōlelo ʻia no ka maʻi maʻi?
he nīnau maʻamau. ʻO nā Plan Nutrition Personalized he mau meaʻai a me nā mea hoʻohui i hoʻopilikino ʻia i kahi hōʻailona maʻi maʻi, genes, nā lāʻau lapaʻau a me nā kūlana ola.

Hoʻoemi ʻo Mannitol iā Cisplatin Chemotherapy Induced Kidjj Injury i nā maʻi maʻi maʻi maʻi

Aug 13, 2021

4.3
(44)
Kuhi manawa heluhelu: 4 mau minuke
Home » Blogs » Hoʻoemi ʻo Mannitol iā Cisplatin Chemotherapy Induced Kidjj Injury i nā maʻi maʻi maʻi maʻi

o ka Naauao

Hoʻohana ʻia ʻo Mannitol, kahi huahana kūlohelohe, ma ke ʻano he diuretic e hoʻonui i ka mimi ʻana i ka poʻe me ka hōʻeha kīwī nui (chemo side-effects). Ua hōʻike ʻia nā noiʻi noiʻi e hoʻohana ana i ka mannitol me Cisplatin chemotherapy e hōʻemi ai i ka ʻeha puʻuwai i hoʻokomo ʻia e Cisplatin, kahi hopena maikaʻi ʻole i ʻike ʻia i ka hapakolu o nā maʻi i mālama ʻia me Cisplatin. Hoʻohana ʻia ʻo Mannitol me Cisplatin hiki ke nephroprotective.



Nā hopena ʻaoʻao ʻo Cisplatin Chemotherapy

ʻO Cisplatin kahi lāʻau lapaʻau i hoʻohana ʻia no ka mālama ʻana i nā maʻi koko paʻa a me kahi maʻamau no ka mālama ʻana i nā maʻi maʻi o ka ʻōpū, ke poʻo a me ka ʻāʻī, ka liʻiliʻi liʻiliʻi a me ka ʻulaʻula liʻiliʻi ʻole. maʻi pū, ovarian, cervical and testicular cancers a me na mea e ae. He mea maikaʻi ʻo Cisplatin i ka hoʻopau ʻana i nā maʻi maʻi maʻi ma o ka hoʻonui ʻana i ke koʻikoʻi oxidative a me ka pōʻino DNA, a laila e hoʻoulu ai i ka make cell cancer. Eia nō naʻe, pili pū ka hoʻohana ʻana o Cisplatin me nā hopena ʻaoʻao like ʻole me nā hopena maʻi, hoʻohaʻahaʻa i ka pale ʻana, nā maʻi ʻōpū, ka cardiotoxicity a me nā pilikia koʻikoʻi. Hoʻokahi hapakolu o ka poʻe maʻi i mālama ʻia me Cisplatin e ʻike i ka pōʻino o ka puʻupaʻa ma hope o ka mālama mua ʻana (Yao X, et al, Am J Med. Sci., 2007). Ua ʻike ʻia ka pōʻino o ka puʻuwai a i ʻole ka nephrotoxicity i hoʻokumu ʻia e Cisplatin ma ke ʻano he hanana ʻino nui (ʻO, Gi-Su, et al. Paʻi Koko Electrolyte, 2014). ʻO kekahi o nā kumu nui no ka nephrotoxicity kiʻekiʻe me Cisplatin no ka mea ʻoi aku ka nui o ka hōʻiliʻili ʻana o ka lāʻau i loko o ka puʻuwai a laila e hoʻonui ana i ka ʻino.

ʻO Mannitol no nā hopena Chemo

Nā Mea ʻai e ʻAi ai Ma hope o ka ʻike maʻi ʻaʻai!

ʻAʻohe ʻelua maʻi ʻaʻai. E hele i waho o nā kulekele meaʻai maʻamau no kēlā me kēia kanaka a hoʻoholo i nā koho pilikino e pili ana i ka meaʻai a me nā mea hoʻopihapiha me ka hilinaʻi.

He aha ʻo Mannitol?

ʻO Mannitol, ka mea i ʻike ʻia me ka waiʻona kō, ʻike ʻia i nā kumuwaiwai kūlohelohe e like me ka ʻalalā, nā strawberry, ke kelala, nā ʻaka, nā ʻumeke a me nā limu kai. Hoʻomaopopo pū ʻia ia me kahi mea palekana e FDA (Food and Drug Administration), a he mea hoʻohana nui ʻia i nā huahana lāʻau.

Nā Pōmaikaʻi / Nā hoʻohana o nā Kākoʻo Mannitol

Eia kekahi o nā hoʻohana maʻamau o mannitol:

  • Hoʻohana mau ʻia ʻo Mannitol ma ke ʻano he diuretic e hoʻonui i ka mimi i nā poʻe me ka hōʻeha kīwī ʻole.
  • Hoʻohana ʻia ʻo Mannitol i nā lāʻau lapaʻau e hoʻemi i ke kaomi a me ka pehu ʻana o ka lolo pū kekahi.
  • Hiki paha iā Mannitol ke kōkua i ka hoʻomaikaʻi ʻana i ke kō kō kō

Nā hopena ʻaoʻao o nā mea kōkua Mannitol

Eia aʻe kekahi o nā hopena hopena maʻamau o nā pākuʻina mannitol:

  • Urination pinepine
  • Hoʻonuiʻia ka puʻuwai o ka naʻau
  • Headaches
  • Hoʻoponopono
  • Dehydration

ʻO Mannitol no ka ʻaoʻao Cisplatin Chemo a me ka ʻeha puʻuwai


Hoʻokahi ala e hoʻoliʻiliʻi i nā hopena chemo e like me nephrotoxicity, ke mālama ʻia me Cisplatin, i loiloi ʻia e ka lāʻau e hoʻohana nei iā Mannitol me Cisplatin chemotherapy.

ʻO ka meaʻai kūpono ma Chemotherapy | Hoʻopilikino ʻia i ka maʻi ʻaʻano Kanaka, Lifestyle & Genetics

Ua nui nā noiʻi kahi i loiloi ai lākou i ka hopena o ka hoʻohana ʻana o Mannitol me Cisplatin chemotherapy ma nā marka nephrotoxicity (chemo ʻaoʻao) e like me nā pae creatinine serum:

  • Ua nānā ʻia kahi haʻawina retrospective mai ke Kulanui o Minnesota Health-Fairview system i nā maʻi 313 i mālama ʻia me Cisplatin (95 i mālama ʻia me ka mannitol a me 218 me ka ʻole), ʻike ʻia ʻo ka hui i hoʻohana i ka Mannitol he haʻahaʻa haʻahaʻa ka piʻi ʻana o nā pae creatinine serum ma mua o ka hui ʻaʻole i hoʻohana. Manitol. Ua emi pinepine ka nephrotoxicity i nā maʻi i loaʻa iā Mannitol ma mua o ka poʻe i loaʻa ʻole - 6-8% me Mannitol vs. 17-23% me ka ʻole o Mannitol (ʻO Williams RP Jr et al, J Oncol Pharm Pract., 2017).
  • ʻO kekahi noi mai ke Kulanui ʻo Emory e pili ana i ka loiloi retrospective pakuhi o nā mea maʻi āpau e loaʻa ana i ka cisplatin me ka radiation pākuʻi no ka carcinoma sāmoa cell o ke poʻo a me ka ʻāʻī. ʻO ka ʻikepili o nā ʻikepili mai nā maʻi 139 (88 me Mannitol a me 51 me ka saline wale nō) i hōʻike ʻia ua hoʻonui ka haʻahaʻa o ka hui Mannitol i ka creatinine serum e hōʻike ana i ka nephrotoxicity haʻahaʻa (ʻO McKibbin T et al, Kākoʻo mālama mālama maʻi maʻi maʻi maʻi, 2016).
  • ʻO kahi noiʻi kikowaena hoʻokahi mai Rigshospitalet a me Herlev haukapila, Denmark, ua hōʻoia pū i nā hopena nephroprotective o ka hoʻohana ʻana o Mannitol ma ke poʻo a me ka ʻāʻī. Ka maʻi 'aʻai nā maʻi e loaʻa ana i ka cisplatin therapy ma kahi hui o 78 mau maʻi (Hagerstrom E, et al, ʻO Clin Med Insights Oncol., 2019).

Panina

Ke kākoʻo nei nā hōʻike lapaʻau ma luna aʻe i ka hoʻohana ʻana i kahi mea palekana a kūlohelohe e like me ka mannitol, e hōʻemi i ka cisplatin-induced koʻikoʻi a me ka hopena koʻikoʻi o ka nephrotoxicity i loko. Ka maʻi 'aʻai maʻi.

He aha nā meaʻai āu e ʻai ai a me nā mea hoʻopihapiha āu e lawe ai i hoʻoholo. Pono e hoʻoholo i kāu hoʻoholo ʻana e pili ana i ka hoʻololi ʻana i nā ʻāpana o ka maʻi ʻaʻai, ka maʻi ʻaʻai, nā lāʻau e hoʻomau nei a me nā mea hoʻopihapiha, nā maʻi āpau, nā ʻike nohona, ke kaupaona, ke kiʻekiʻe a me nā ʻano.

ʻAʻole hoʻokumu ʻia ka hoʻolālā meaʻai no ka maʻi ʻaʻai mai addon ma ka ʻimi pūnaewele. Hoʻokele ia i ka hoʻoholo ʻana iā ʻoe ma muli o ka ʻepekema molekole i hoʻokō ʻia e ko mākou ʻepekema a me nā ʻenekini polokalamu. Nānā ʻole inā ʻoe e noʻonoʻo e hoʻomaopopo i ke ʻano o nā ʻolaola biōmika kumu a i ʻole ʻole - no ka hoʻolālā meaʻai no ka maʻi ʻaʻai e pono ai ka ʻike.

E hoʻomaka I K NOWIA manawa me kāu hoʻolālā meaʻai e ka pane ʻana i nā nīnau e pili ana i ka inoa o ka maʻi ʻaʻai, ka hoʻololi ʻana o nā kūpuna, nā mālama ʻana a me nā mea hoʻopihapiha mau, nā maʻi āpau, nā ʻano, ka nohona, nā makahiki a me nā kāne.

hōʻike hōʻike

Mea 'ai pilikino no ka ma'i 'a'ai!

Hoʻololi ka maʻi kanesa me ka manawa. Hoʻopilikino a hoʻololi i kāu meaʻai e pili ana i ka hōʻailona maʻi maʻi, ka mālama ʻana, ke ʻano o ka nohona, nā makemake meaʻai, nā allergies a me nā mea ʻē aʻe.


ʻO nā mea maʻi maʻi maʻi e hana pinepine me nā mea ʻokoʻa nā hopena ʻaoʻao chemotherapy kahi e hoʻopili ai i ko lākou ola o ke ola a nānā i nā hoʻoponopono ʻokoʻa no ka maʻi ʻaʻai. Lawe ana i ka ka meaʻai kūpono a me nā mea hoʻopihapiha e pili ana i nā noʻonoʻo ʻepekema (ka hōʻalo ʻana i ka wānana a me ke koho wale ʻana) ʻo ia ka lāʻau kūlohelohe maikaʻi loa no ka maʻi ʻaʻai a me nā lāʻau e pili ana i nā hopena ʻaoʻao.


Nānā ʻepekema e: Kauka Cogle

ʻO Christopher R. Cogle, MD he polopeka paʻa ma ke Kulanui o Florida, Luna Lapaʻau Nui o Florida Medicaid, a me Luna Hoʻokele o ka Florida Health Policy Leadership Academy ma ka Bob Graham Center for Public Service.

Hiki iā ʻoe ke heluhelu i kēia ma

Pehea ka waiwai o kēia kūlana?

Kaomi ma ka hōkū no ke kohoʻana!

Pane pālākio waena 4.3 / 5. Helu helu: 44

ʻAʻole i koho balota a hiki i kēia wā. ʻO ia ka mea e helu i kēia pou

Loaʻa iāʻoe kēia kūlana kūpono ...

E hahai iā mākou ma ka pāʻina kaiaulu!

Ke mihi nei mākou no ka ponoʻole o kēia pou iāʻoe!

E hoʻonui kākou i kēia kūlana!

E haʻi mai iā mākou pehea mākou e hoʻonui ai i kēia pou?